Becky M Smith

Becky M. Smith serves as a Purchasing Agent at Naval Hospital (N68095), supporting the Department of the Navy’s mission to sustain combat-ready medical forces through timely and compliant acquisition of critical healthcare infrastructure and diagnostic equipment. In this role, she manages the full lifecycle of procurement actions for clinical, laboratory, and surgical support systems, ensuring alignment with FAR regulations and Department of Defense procurement policies. Her acquisitions primarily focus on high-integrity medical devices, in-vitro diagnostic substances, and analytical instrumentation essential to point-of-care diagnostics and sterile operational environments. Smith maintains collaborative relationships with a diverse base of vendors specializing in medical manufacturing and laboratory supply chains, including firms certified under small business programs and established industrial suppliers of precision instrumentation. While her contracting patterns reflect a primary reliance on open competition—approximately 82% of awards are non-set-aside—she actively engages with small business partners, particularly those certified as Service-Disabled Veteran-Owned Small Businesses and general Small Business concerns under FAR 19.5. Her vendor partnerships emphasize technical reliability, regulatory compliance, and rapid delivery capabilities to meet the Navy’s dynamic clinical demands. Her procurement focus is concentrated in key NAICS categories, including Surgical and Medical Instrument Manufacturing (339112), In-Vitro Diagnostic Substance Manufacturing (325413), and Analytical Laboratory Instrument Manufacturing (334516), reflecting a deep specialization in diagnostic and clinical support technologies. She also regularly procures industrial gases and specialized maintenance services under NAICS 811219, underscoring her expertise in sustaining sterile, high-reliability medical environments. Smith’s work ensures the Naval Hospital maintains operational readiness through the strategic acquisition of mission-critical medical technologies and supply chain resilience.